Report overview
Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their ?bulk? counterparts primarily because of size.
There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.
This report aims to provide a comprehensive presentation of the global market for Nanopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanopharmaceuticals. This report contains market size and forecasts of Nanopharmaceuticals in global, including the following market information:
Global Nanopharmaceuticals Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Nanopharmaceuticals Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Nanopharmaceuticals companies in 2022 (%)
The global Nanopharmaceuticals market was valued at US$ 31860 million in 2022 and is projected to reach US$ 72390 million by 2029, at a CAGR of 12.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USA is the largest Nanopharmaceuticals market with about 59% market share. Europe is follower, accounting for about 33% market share.
The key players are Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Celgene, Novavax, Stryker, Gilead Sciences, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy etc. Top 3 companies occupied about 34% market share.
We surveyed the Nanopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanopharmaceuticals Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Nanopharmaceuticals Market Segment Percentages, by Type, 2022 (%)
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension
Global Nanopharmaceuticals Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Nanopharmaceuticals Market Segment Percentages, by Application, 2022 (%)
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others
Global Nanopharmaceuticals Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Nanopharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nanopharmaceuticals revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Nanopharmaceuticals revenues share in global market, 2022 (%)
Key companies Nanopharmaceuticals sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Nanopharmaceuticals sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nanopharmaceuticals, market overview.
Chapter 2: Global Nanopharmaceuticals market size in revenue and volume.
Chapter 3: Detailed analysis of Nanopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nanopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nanopharmaceuticals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
